1,10-phenanthroline increases expression ISO RGD:1315034 6480464 1, 10-phenanthroline results in increased expression of CA9 mRNA CTD PMID:19502547 1,2-dimethylhydrazine decreases expression ISO RGD:1315035 6480464 1, 2-Dimethylhydrazine results in decreased expression of CAR9 mRNA CTD PMID:22206623 17beta-estradiol decreases expression ISO RGD:1315034 6480464 Estradiol results in decreased expression of CA9 mRNA CTD PMID:20106945 , PMID:21632981 17beta-estradiol multiple interactions ISO RGD:1315034 6480464 [Estradiol co-treated with TGFB1 protein] results in decreased expression of CA9 mRNA CTD PMID:30165855 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315034 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA], Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:19154183 2,3,7,8-tetrachlorodibenzodioxine increases expression EXP 6480464 Tetrachlorodibenzodioxin results in increased expression of CAR9 mRNA CTD PMID:33387578 2,3,7,8-tetrachlorodibenzodioxine multiple interactions ISO RGD:1315035 6480464 Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:19154183 2-hydroxypropanoic acid decreases expression ISO RGD:1315034 6480464 Lactic Acid results in decreased expression of CA9 mRNA CTD PMID:30851411 3,3',5,5'-tetrabromobisphenol A decreases expression ISO RGD:1315035 6480464 tetrabromobisphenol A results in decreased expression of CAR9 mRNA CTD PMID:25172293 4,4'-sulfonyldiphenol decreases expression ISO RGD:1315034 6480464 bis(4-hydroxyphenyl)sulfone results in decreased expression of CA9 mRNA CTD PMID:27685785 4,4'-sulfonyldiphenol affects methylation ISO RGD:1315035 6480464 bis(4-hydroxyphenyl)sulfone affects the methylation of CAR9 gene CTD PMID:31683443 4,4'-sulfonyldiphenol increases expression ISO RGD:1315035 6480464 bis(4-hydroxyphenyl)sulfone results in increased expression of CAR9 mRNA CTD PMID:30951980 4-methylumbelliferyl beta-D-galactoside decreases activity ISO RGD:1315034 6480464 4-methylumbelliferyl-galactopyranoside analog results in decreased activity of CA9 protein CTD PMID:22077347 4-nitrophenol decreases expression ISO RGD:1315035 6480464 4-nitrophenol results in decreased expression of CAR9 mRNA CTD PMID:34673133 acetamide increases expression EXP 6480464 acetamide results in increased expression of CA9 mRNA CTD PMID:31881176 acetazolamide decreases activity ISO RGD:1315034 6480464 Acetazolamide results in decreased activity of CA9 protein CTD PMID:21851094 acetazolamide multiple interactions ISO RGD:1315034 6480464 Acetazolamide binds to and results in decreased activity of CA9 protein CTD PMID:28251759 acrylamide decreases expression ISO RGD:1315034 6480464 Acrylamide results in decreased expression of CA9 mRNA CTD PMID:32763439 amphotericin B decreases expression ISO RGD:1315034 6480464 Amphotericin B analog results in decreased expression of CA9 mRNA CTD PMID:28534445 ampicillin increases expression ISO RGD:1315034 6480464 Ampicillin results in increased expression of CA9 mRNA CTD PMID:21632981 antirheumatic drug decreases expression ISO RGD:1315034 6480464 Antirheumatic Agents results in decreased expression of CA9 mRNA CTD PMID:24449571 Archazolid B increases expression ISO RGD:1315034 6480464 archazolid B results in increased expression of CA9 mRNA CTD PMID:25218289 aristolochic acid A decreases expression ISO RGD:1315034 6480464 aristolochic acid I results in decreased expression of CA9 mRNA CTD PMID:33212167 arsenous acid multiple interactions ISO RGD:1315034 6480464 Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA] CTD PMID:21969006 arsenous acid decreases expression ISO RGD:1315034 6480464 Arsenic Trioxide results in decreased expression of CA9 mRNA CTD PMID:21969006 benzo[a]pyrene decreases expression ISO RGD:1315034 6480464 Benzo(a)pyrene results in decreased expression of CA9 mRNA CTD PMID:20228066 , PMID:35870112 benzo[a]pyrene decreases methylation ISO RGD:1315034 6480464 Benzo(a)pyrene results in decreased methylation of CA9 exon CTD PMID:27901495 benzo[a]pyrene affects methylation ISO RGD:1315034 6480464 Benzo(a)pyrene affects the methylation of CA9 promoter CTD PMID:27901495 benzo[a]pyrene multiple interactions ISO RGD:1315034 6480464 Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA], Benzo(a)pyrene inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein] CTD PMID:20228066 betulin multiple interactions ISO RGD:1315034 6480464 betulin analog inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:26540049 betulinic acid decreases activity ISO RGD:1315034 6480464 Betulinic Acid analog results in decreased activity of CA9 protein CTD PMID:29454615 betulinic acid multiple interactions ISO RGD:1315034 6480464 Betulinic Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:26540049 bezafibrate multiple interactions ISO RGD:1315034 6480464 Bezafibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:34520103 bisphenol A decreases expression EXP 6480464 bisphenol A results in decreased expression of CA9 mRNA CTD PMID:25181051 more ... bisphenol A increases expression ISO RGD:1315034 6480464 bisphenol A results in increased expression of CA9 mRNA CTD PMID:31715268 bisphenol A increases expression ISO RGD:1315035 6480464 bisphenol A results in increased expression of CAR9 mRNA CTD PMID:30245210 , PMID:32156529 bisphenol A affects expression ISO RGD:1315034 6480464 bisphenol A affects the expression of CA9 mRNA CTD PMID:30903817 bleomycin A5 decreases response to substance ISO RGD:1315034 6480464 CA9 protein results in decreased susceptibility to bleomycetin CTD PMID:21040473 bleomycin A5 increases expression ISO RGD:1315034 6480464 bleomycetin results in increased expression of CA9 mRNA, bleomycetin results in increased expression of CA9 protein CTD PMID:21040473 bleomycin A5 multiple interactions ISO RGD:1315034 6480464 CA9 protein inhibits the reaction [bleomycetin results in increased activity of CASP3 protein] CTD PMID:21040473 bortezomib decreases expression ISO RGD:1315034 6480464 Bortezomib results in decreased expression of CA9 protein CTD PMID:16061869 butanal decreases expression ISO RGD:1315034 6480464 butyraldehyde results in decreased expression of CA9 mRNA CTD PMID:25014914 , PMID:26079696 butyric acid multiple interactions ISO RGD:1315034 6480464 Butyric Acid inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:26305601 calcitriol increases expression ISO RGD:1315034 6480464 Calcitriol results in increased expression of CA9 mRNA CTD PMID:26485663 captan increases expression ISO RGD:1315035 6480464 Captan results in increased expression of CAR9 mRNA CTD PMID:31558096 carbonates decreases activity ISO RGD:1315034 6480464 Carbonates results in decreased activity of CA9 protein CTD PMID:15664814 CAY10591 multiple interactions ISO RGD:1315034 6480464 CAY10591 inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:34520103 CGP 52608 multiple interactions ISO RGD:1315034 6480464 CGP 52608 promotes the reaction [RORA protein binds to CA9 gene] CTD PMID:28238834 chloric acid decreases activity ISO RGD:1315034 6480464 chloric acid results in decreased activity of CA9 protein CTD PMID:15664814 chlorpyrifos decreases expression ISO RGD:1315035 6480464 Chlorpyrifos results in decreased expression of CAR9 mRNA CTD PMID:37019170 cisplatin decreases expression ISO RGD:1315034 6480464 Cisplatin results in decreased expression of CA9 mRNA CTD PMID:27392435 clofibrate multiple interactions ISO RGD:1315034 6480464 Clofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:34520103 cobalt atom multiple interactions ISO RGD:1315034 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of CA9 mRNA CTD PMID:20105288 cobalt dichloride multiple interactions ISO RGD:1315034 6480464 2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein] more ... CTD PMID:19808899 more ... cobalt dichloride increases expression EXP 6480464 cobaltous chloride results in increased expression of CAR9 mRNA CTD PMID:24386269 cobalt dichloride increases expression ISO RGD:1315035 6480464 cobaltous chloride results in increased expression of CAR9 mRNA CTD PMID:24265542 cobalt dichloride multiple interactions ISO RGD:1315035 6480464 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole inhibits the reaction [cobaltous chloride results in increased expression of CAR9 mRNA] CTD PMID:24265542 cobalt dichloride increases expression ISO RGD:1315034 6480464 cobaltous chloride results in increased expression of CA9 mRNA, cobaltous chloride results in increased expression of CA9 protein CTD PMID:19376846 more ... cobalt(2+) sulfate increases expression ISO RGD:1315034 6480464 cobalt sulfate results in increased expression of CA9 mRNA CTD PMID:19502547 crocidolite asbestos increases expression ISO RGD:1315034 6480464 Asbestos, Crocidolite results in increased expression of CA9 mRNA CTD PMID:29523930 curcumin decreases expression EXP 6480464 Curcumin results in decreased expression of CAR9 mRNA CTD PMID:18299980 cyclosporin A decreases expression ISO RGD:1315034 6480464 Cyclosporine results in decreased expression of CA9 mRNA CTD PMID:20106945 , PMID:21632981 deguelin multiple interactions ISO RGD:1315034 6480464 deguelin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:22745725 desferrioxamine B increases expression ISO RGD:1315034 6480464 Deferoxamine results in increased expression of CA9 mRNA CTD PMID:25351418 diarsenic trioxide decreases expression ISO RGD:1315034 6480464 Arsenic Trioxide results in decreased expression of CA9 mRNA CTD PMID:21969006 diarsenic trioxide multiple interactions ISO RGD:1315034 6480464 Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA] CTD PMID:21969006 dimethylarsinous acid decreases expression ISO RGD:1315034 6480464 dimethylarsinous acid results in decreased expression of CA9 mRNA CTD PMID:23876855 dioxygen multiple interactions ISO RGD:1315034 6480464 (+)-JQ1 compound inhibits the reaction [Oxygen deficiency promotes the reaction [ARNT protein binds to CA9 promoter]] more ... CTD PMID:19154183 more ... dioxygen increases expression EXP 6480464 Oxygen deficiency results in increased expression of CAR9 protein CTD PMID:36527649 dioxygen increases expression ISO RGD:1315034 6480464 [Oxygen deficiency results in increased expression of CA9 mRNA] which results in increased expression of ABCC2 mRNA more ... CTD PMID:18924134 more ... dioxygen increases expression ISO RGD:1315035 6480464 Oxygen deficiency results in increased expression of CA9, Oxygen deficiency results in increased expression of CA9 mRNA CTD PMID:19154183 , PMID:21361354 dioxygen multiple interactions ISO RGD:1315035 6480464 ARNT protein affects the reaction [Oxygen deficiency results in increased expression of CA9 mRNA], Tetrachlorodibenzodioxin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:19154183 doxorubicin decreases expression ISO RGD:1315034 6480464 Doxorubicin results in decreased expression of CA9 mRNA CTD PMID:22908232 ethanol multiple interactions ISO RGD:1315034 6480464 [[Gasoline co-treated with Ethanol] results in increased abundance of [Particulate Matter co-treated with Polycyclic Aromatic Hydrocarbons]] which results in decreased expression of CA9 mRNA CTD PMID:29432896 fenofibrate multiple interactions ISO RGD:1315034 6480464 Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA], Fenofibrate inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:34520103 folpet increases expression ISO RGD:1315035 6480464 folpet results in increased expression of CAR9 mRNA CTD PMID:31558096 gemfibrozil multiple interactions ISO RGD:1315034 6480464 Gemfibrozil inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:34520103 Genipin multiple interactions ISO RGD:1315034 6480464 genipin inhibits the reaction [Oxygen deficiency results in increased expression of CA9 mRNA] CTD PMID:29630948 heptanal decreases expression ISO RGD:1315034 6480464 heptanal results in decreased expression of CA9 mRNA CTD PMID:25014914 hexanal decreases expression ISO RGD:1315034 6480464 n-hexanal results in decreased expression of CA9 mRNA CTD PMID:25014914 hydroquinone decreases expression ISO RGD:1315034 6480464 hydroquinone results in decreased expression of CA9 mRNA CTD PMID:31256213 iron(III) citrate decreases expression ISO RGD:1315034 6480464 ferric citrate results in decreased expression of CA9 mRNA CTD PMID:29959986 L-ascorbic acid multiple interactions ISO RGD:1315034 6480464 Ascorbic Acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein] CTD PMID:16288478 lead(0) affects expression ISO RGD:1315034 6480464 Lead affects the expression of CA9 mRNA CTD PMID:28903495 LY294002 multiple interactions ISO RGD:1315034 6480464 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein] more ... CTD PMID:19808899 molybdate decreases activity ISO RGD:1315034 6480464 molybdate results in decreased activity of CA9 protein CTD PMID:15664814 N-Nitrosopyrrolidine decreases expression ISO RGD:1315034 6480464 N-Nitrosopyrrolidine results in decreased expression of CA9 mRNA CTD PMID:32234424 nickel dichloride increases expression ISO RGD:1315034 6480464 nickel chloride results in increased expression of CA9 mRNA CTD PMID:21455298 , PMID:28552779 nickel dichloride multiple interactions ISO RGD:1315034 6480464 HIF1A protein promotes the reaction [nickel chloride results in increased expression of CA9 protein] CTD PMID:28552779 nickel sulfate multiple interactions ISO RGD:1315034 6480464 Ascorbic Acid inhibits the reaction [nickel sulfate results in increased expression of CA9 protein] CTD PMID:16288478 nickel sulfate decreases expression ISO RGD:1315034 6480464 nickel sulfate results in decreased expression of CA9 mRNA CTD PMID:22714537 nickel sulfate increases expression ISO RGD:1315034 6480464 nickel sulfate results in increased expression of CA9 protein CTD PMID:16288478 nitric acid decreases activity ISO RGD:1315034 6480464 Nitric Acid results in decreased activity of CA9 protein CTD PMID:15664814 Nonidet P-40 decreases expression ISO RGD:1315034 6480464 Nonidet P-40 results in decreased expression of CA9 mRNA CTD PMID:26552463 O-methyleugenol decreases expression ISO RGD:1315034 6480464 methyleugenol results in decreased expression of CA9 mRNA CTD PMID:32234424 octanal decreases expression ISO RGD:1315034 6480464 caprylic aldehyde results in decreased expression of CA9 mRNA CTD PMID:25014914 oryzalin multiple interactions ISO RGD:1315034 6480464 oryzalin binds to and results in decreased activity of CA9 protein CTD PMID:28251759 oxaliplatin decreases expression ISO RGD:1315034 6480464 oxaliplatin results in decreased expression of CA9 mRNA CTD PMID:17762391 paracetamol decreases expression ISO RGD:1315034 6480464 Acetaminophen results in decreased expression of CA9 mRNA CTD PMID:29067470 paracetamol decreases expression EXP 6480464 Acetaminophen results in decreased expression of CAR9 mRNA CTD PMID:33387578 pentanal decreases expression ISO RGD:1315034 6480464 pentanal results in decreased expression of CA9 mRNA CTD PMID:25014914 , PMID:26079696 perchlorate decreases activity ISO RGD:1315034 6480464 perchlorate results in decreased activity of CA9 protein CTD PMID:15664814 perfluorooctanoic acid decreases expression ISO RGD:1315034 6480464 perfluorooctanoic acid results in decreased expression of CA9 mRNA CTD PMID:23978341 phenobarbital affects expression ISO RGD:1315034 6480464 Phenobarbital affects the expression of CA9 mRNA CTD PMID:19159669 pirinixic acid decreases expression ISO RGD:1315035 6480464 pirinixic acid results in decreased expression of CAR9 mRNA CTD PMID:17426115 , PMID:23811191 pregnenolone 16alpha-carbonitrile increases expression ISO RGD:1315035 6480464 Pregnenolone Carbonitrile results in increased expression of CAR9 mRNA CTD PMID:22698814 propanal decreases expression ISO RGD:1315034 6480464 propionaldehyde results in decreased expression of CA9 mRNA CTD PMID:25014914 , PMID:26079696 rac-lactic acid decreases expression ISO RGD:1315034 6480464 Lactic Acid results in decreased expression of CA9 mRNA CTD PMID:30851411 resveratrol multiple interactions ISO RGD:1315034 6480464 [Plant Extracts co-treated with Resveratrol] results in decreased expression of CA9 mRNA CTD PMID:23557933 serpentine asbestos increases expression ISO RGD:1315034 6480464 Asbestos, Serpentine results in increased expression of CA9 mRNA CTD PMID:29523930 silibinin multiple interactions ISO RGD:1315034 6480464 Arsenic Trioxide promotes the reaction [Silybin results in decreased expression of CA9 mRNA] CTD PMID:21969006 silibinin decreases expression ISO RGD:1315034 6480464 Silybin results in decreased expression of CA9 mRNA CTD PMID:21969006 silicon dioxide decreases expression ISO RGD:1315034 6480464 Silicon Dioxide analog results in decreased expression of CA9 mRNA CTD PMID:25895662 silicon dioxide increases expression ISO RGD:1315034 6480464 Silicon Dioxide results in increased expression of CA9 mRNA CTD PMID:25351596 sodium arsenite affects expression ISO RGD:1315034 6480464 sodium arsenite affects the expression of CA9 mRNA CTD PMID:29319823 sodium arsenite increases expression ISO RGD:1315034 6480464 sodium arsenite results in increased expression of CA9 mRNA CTD PMID:29301061 sodium dichromate increases expression ISO RGD:1315035 6480464 sodium bichromate results in increased expression of CAR9 mRNA CTD PMID:31558096 sotorasib multiple interactions ISO RGD:1315034 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CA9 mRNA CTD PMID:36139627 sulfamic acid decreases activity ISO RGD:1315034 6480464 sulfamic acid results in decreased activity of CA9 protein CTD PMID:15664814 sulfates decreases activity ISO RGD:1315034 6480464 Sulfates results in decreased activity of CA9 protein CTD PMID:15664814 sulindac decreases expression ISO RGD:1315034 6480464 Sulindac analog results in decreased expression of CA9 mRNA CTD PMID:18924134 temozolomide increases expression ISO RGD:1315034 6480464 Temozolomide results in increased expression of CA9 mRNA CTD PMID:31758290 trametinib multiple interactions ISO RGD:1315034 6480464 [sotorasib co-treated with trametinib co-treated with NVP-BKM120] results in decreased expression of CA9 mRNA CTD PMID:36139627 tributylstannane increases expression EXP 6480464 tributyltin results in increased expression of CAR9 mRNA CTD PMID:21683754 Triptolide multiple interactions ISO RGD:1315034 6480464 triptolide inhibits the reaction [cobaltous chloride results in increased expression of CA9 protein] CTD PMID:24842335 tungstate decreases activity ISO RGD:1315034 6480464 tungstate results in decreased activity of CA9 protein CTD PMID:15664814 Tungsten carbide multiple interactions ISO RGD:1315034 6480464 [tungsten carbide binds to Cobalt] which results in increased expression of CA9 mRNA CTD PMID:20105288 Tungsten carbide increases expression ISO RGD:1315034 6480464 tungsten carbide results in increased expression of CA9 mRNA CTD PMID:20105288 urethane affects expression ISO RGD:1315034 6480464 Urethane affects the expression of CA9 mRNA CTD PMID:28818685 valproic acid increases expression EXP 6480464 Valproic Acid results in increased expression of CAR9 mRNA CTD PMID:35594946 vorinostat multiple interactions ISO RGD:1315034 6480464 vorinostat inhibits the reaction [Oxygen deficiency results in increased expression of CA9 protein] CTD PMID:26305601 zinc dichloride multiple interactions ISO RGD:1315034 6480464 zinc chloride inhibits the reaction [cobaltous chloride results in increased expression of CA9 mRNA] CTD PMID:22202117